Related Experiment Video
Updated: Dec 12, 2025
10:03
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
10.1K
Induced Pluripotent Stem Cell Meets Severe Combined Immunodeficiency.
Reza Kouchaki1, Bahareh Abd-Nikfarjam2, Amir Hosein Maali3
1Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Cell Journal
|August 12, 2020
Summary
Induced pluripotent stem cells (iPSC) offer new hope for treating severe combined immunodeficiency (SCID). This approach involves gene-corrected stem cell transplantation for SCID and aids in disease modeling.
Area of Science:
- Immunology
- Stem Cell Biology
- Genetic Engineering
Background:
- Severe combined immunodeficiency (SCID) is a primary immunodeficiency impairing T-lymphocyte differentiation, with genetic defects in genes like IL2RG and JAK3.
- Current hematopoietic stem cell (HSC) gene therapy (GT) for SCID faces challenges.
- Induced pluripotent stem cells (iPSC), generated via Yamanaka factors, represent a significant advancement in regenerative medicine.
Purpose of the Study:
- To review the application of iPSC-based gene therapy (GT) for SCID.
- To explore the use of iPSC technology in modeling SCID and discovering new drugs.
- To discuss novel approaches for iPSC applications in SCID treatment.
Main Methods:
- Review of current literature on iPSC technology and its application in SCID.
- Discussion of gene correction strategies for iPSC-derived HSC before transplantation.
- Exploration of iPSC-based cellular and molecular disease modeling.
Main Results:
- iPSC technology enables the generation of patient-specific HSC for potential transplantation in SCID.
- Gene correction in iPSC is a prerequisite for successful SCID transplantation.
- iPSC serve as a valuable platform for disease modeling and drug discovery in SCID.
Conclusions:
- iPSC-based HSC transplantation holds promise for treating SCID and other genetic disorders.
- iPSC technology offers innovative avenues for SCID research, including disease modeling and therapeutic development.
- Further advancements in iPSC technology are crucial for overcoming challenges in SCID treatment.
Related Concept Videos
01:25Immunodeficiency Diseases
1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.8K
01:13Induced Pluripotent Stem Cells
26.7K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
26.7K
01:06Induced Pluripotent Stem Cells
5.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.1K
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:21EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
01:17Stem Cell Culture
5.9K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.9K